Loading
ZL
ZYUS Life Sciences Corporation Stock: price and insider trades · Canada
ZYUS Life Sciences Corporation: what insiders have been doing
Every trade that managers of ZYUS Life Sciences Corporation disclose to SEDI is tracked on this page. The company sits in the Health Care sector. 2 insiders have disclosed 2 filings since 23 October 2025.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
There has been no open-market purchase by an insider of ZYUS Life Sciences Corporation for at least a year.
Compared with its exchange (2,471 companies, median 12 filings), a count of 2 filings is below the norm. Since 2023, the database holds 4 purchases and no sales by insiders of the company.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
22
Thresholds
n/a
Buy Volume
€3,147
4 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
CA$0.50
Analyst consensus
Income statement
RevenueCA$405k
Gross profitCA$50k12% margin
EBITDA-CA$16.6M-4099% margin
Net income-CA$21.7M-5365.7% margin
Valuation
Beta0.16
Balance sheet & cash
Market capCA$40M
Total debtCA$15.9M
Free Cash Flow-CA$9.2M
Profitability & ownership
ROA-87.3%
% insiders51.4%
% institutions0.0%
Last declaration on 23 October 2026
Declarations22 total
111,111 shares@ CA$0.45Common SharesTSXSEDI:4793944
41,058 shares@ CA$0.6533.3% of flowCommon SharesTSXSEDI:4612539
74,627 shares@ CA$0.67100.0% of flowCommon SharesTSXSEDI:4537743
373,134 shares@ CA$0.67100.0% of flowCommon SharesTSXSEDI:4536599
298,507 shares@ CA$0.67100.0% of flowCommon SharesTSXSEDI:4536593
25,500 sharesCommon SharesTSXSEDI:4454928
25,500 sharesCommon SharesTSXSEDI:4454927
184,000 shares@ CA$0.9248.1% of flowCommon SharesTSXSEDI:4250945
Common SharesTSXSEDI:4250944
184,000 shares@ CA$0.92100.0% of flowCommon SharesTSXSEDI:4250941
Common SharesTSXSEDI:4248114
250,000 sharesCommon SharesTSXSEDI:4232597
1,650 shares@ CA$0.89100.0% of flowCommon SharesTSXSEDI:4227936
Canonical exit: 17 Mar 2024 (T+90)
600 shares@ CA$1.03Common SharesTSXSEDI:4188697
Canonical exit: 27 Dec 2023 (T+90)
900 shares@ CA$1.01Common SharesTSXSEDI:4188696
Canonical exit: 26 Dec 2023 (T+90)
1,500 shares@ CA$1.02Common SharesTSXSEDI:4186260
Canonical exit: 18 Dec 2023 (T+90)
Common SharesTSXSEDI:4144493
Common SharesTSXSEDI:4145003
Common SharesTSXSEDI:4144817
Common SharesTSXSEDI:4144989
Common SharesTSXSEDI:4145000
Common SharesTSXSEDI:4144819
22 of 22 declarations
About ZYUS Life Sciences Corporation
ZYUS Life Sciences Corporation is a company focused on developing health products based on cannabis. It is listed on the Toronto Stock Exchange under the symbol XTSE.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
